Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities

Core Insights - Aethlon Medical is evaluating strategic opportunities and has engaged Maxim Group LLC as its exclusive financial advisor to assist in this process [1] - The company has received preliminary interest regarding potential strategic opportunities, including partnerships, mergers, and acquisitions [1] - Aethlon has completed the second cohort of its Australian oncology trial, with safety data to be submitted for review [1] Company Overview - Aethlon Medical, Inc. is a clinical-stage medical device company focused on developing products to treat cancer and life-threatening infectious diseases [1] - The company is advancing the Hemopurifier, a novel platform designed to selectively remove pathogenic targets from biological fluids [1] Financial Advisory Engagement - Maxim Group LLC, founded in 2002, is a full-service investment bank providing a range of financial services, including investment banking and equity research [1] - The engagement with Maxim is part of Aethlon's ongoing efforts to assess opportunities for the company and its shareholders [1]